Amgen Inc v. Hikma Pharmaceuticals USA Inc
Amgen Inc v. Hikma Pharmaceuticals USA Inc is a federal patent lawsuit filed on 06/25/2025 in the District Court, D. New Jersey. The case is currently open in the federal court system.
- Court
- District Court, D. New Jersey (D.N.J.)
Official Court Website → - Assigned judge
- Christine P. O'Hearn · 280 cases in index
- Docket number
- 1:25-cv-12152
- Cause
- 35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement - Nature of suit
- 830 Patent
Infringement of a patented invention. - Jurisdiction
- Federal Question
- Jury demand
- Plaintiff
- Date filed
- 06/25/2025
3,648 Patent cases in this court are indexed here.
Parties
- plaintiff · Amgen, Inc Pharmaceuticals & Biotechnology · 229 cases
- defendant · Hikma Pharmaceuticals USA, Inc · 25 cases
Part of a Larger Litigation Pattern
This is one of 26 Patent cases in our index naming HIKMA PHARMACEUTICALS USA, INC — a possible mass-tort or coordinated-litigation cluster.
About Patent Lawsuits
Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
Frequently Asked Questions
What is Amgen Inc v. Hikma Pharmaceuticals USA Inc?
Amgen Inc v. Hikma Pharmaceuticals USA Inc is a federal patent lawsuit filed on 06/25/2025 in the District Court, D. New Jersey. The case is currently open in the federal court system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
What type of case is this?
It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
What court is the case in?
The case is in the District Court, D. New Jersey, docket number 1:25-cv-12152.
When was the case filed?
Amgen Inc v. Hikma Pharmaceuticals USA Inc was filed on 06/25/2025. The case is currently open.
What law is the case brought under?
The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.
Other Cases Involving These Parties
Related Patent Cases
Source: public U.S. federal court record (docket 70633815).